Back to BlackRock, Inc. BlackRock, Inc.

VKTXVKTX
8 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in VIKING THERAPEUTICS INC

Yes. BlackRock holds 6,189,649 shares of VKTX (Viking Therapeutics), worth $241.5M, as of its Q2 2026 13F filing. It reduced the position by 690,641 shares (-10.0%) from Q1 2026. BlackRock has held VKTX in every 13F on record since Q3 2024, 8 quarterly filings.

Current Value

$241.5M

Current Shares

6.2M

Total Value Change

-$99.2M

Total Shares Change

+809,326

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
6.2M
-10.0%
$241.5M0.0%$39.01
0
2026-Q1
Increased
6.9M
+4.1%
$223.9M0.0%$32.54
32
2025-Q4
Increased
6.6M
+18.1%
$232.6M0.0%$35.18
36
2025-Q3
Increased
5.6M
+2.9%
$147.1M0.0%$26.28
31
2025-Q2
Decreased
5.4M
-9.0%
$144.1M0.0%$26.50
0
2025-Q1
Increased
6M
+1.8%
$144.3M0.0%$24.15
31
2024-Q4
Increased
5.9M
+9.2%
$236.3M0.0%$40.24
34
2024-Q3
First report
5.4M
-
$340.6M0.0%$63.31
0

Other major holders of VKTX: FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used